Cameron Brink achieves visual freedom with the EVO implantable lenses

Basketball Player

Cam Brink 80 41

Vision struggles on and off the court

Cameron Brink, a star on the women’s basketball team of Stanford University, faced the daily struggles of glasses and contacts, impacting both her personal and professional life.

Do I Qualify?
Cameron Brink High Res v2

EVO ICL: the game-changer

Cameron's vision problems started in the 5th grade when glasses became a part of her daily life. Later, her reliance on visual aids expanded to contacts, introducing a new set of challenges. For approximately 12 years, Cameron navigated the world through glasses and contacts. "I've been wearing glasses or contacts since I was in the 5th grade. And started to struggle with eye dryness and irritation. As a basketball player, I was constantly losing my contacts during games and practice!" The burden of being nearsighted became an accepted norm… until Cameron learned about the EVO Implantable Collamer® Lenses (EVO ICL).
Cameron's decision to correct her nearsightedness with the EVO ICL procedure was fueled by the desire to break free from the constraints of traditional vision correction methods. With EVO ICL, Cameron's life took a remarkable positive turn. "My life has changed for the better! I don't have to fumble with contacts anymore when I wake up or during the day, and my eyes aren't irritated anymore. Plus, I don't have to worry about losing lenses on the court!"
The differences post-EVO ICL are noticeable. In Cameron's words, "my eyes aren't irritated and dry like they were when I wore contacts. And I love waking up in the morning seeing clearly." Cameron emphasizes the life-changing benefits that extend beyond the basketball court. Choosing EVO ICL was not just about vision correction; it was a lifestyle choice. "The time I save each day! Living a life free of contacts was a huge selling point; as well as the fact that the EVO lens implant is reversible if I ever need it."
Cam Brink1
Cam Brink5
Cam Brink6

Join her in experiencing the world with newfound clarity and confidence. For those on the fence about EVO ICL, Cameron passionately encourages,

"Talk to your eye doctor today. It's truly a life-changing procedure!"

Ready to embrace a life without the hassle of glasses and contacts? Discover the possibilities with EVO ICL. Call an EVO advisor today to schedule an appointment with an eye doctor near you, and embark on your own journey towards visual freedom!

Cameron Brink has EVO ICL lenses and is sponsored by STAAR Surgical.

Dôležité bezpečnostné informácie pre EVO/EVO+ ICL

EVO/EVO+ ICL je určený na korekciu/zníženie krátkozrakosti do -20 dioptrií (D) a astigmatizmu do 6 D pre pacientov vo veku 21 až 60 rokov, prípadne pre pacientov starších než 21 rokov, ktorí boli už liečení vnútroočnou šošovkou. Implantácia EVO/EVO+ ICL je chirurgický zákrok, a preto so sebou nesie určité riziká. Medzi potenciálne komplikácie/podujatia patria: ďalšie operácie, vznik katarakty, prechodná alebo trvalá strata najlepšej upravenej ostrosti zraku, zvýšený vnútroočný tlak, strata buniek na najvnútornejšom povrchu rohovky, podráždenie spojivky, opuch rohovky, infekcia oka, dislokácie EVO/EVO+ ICL, makulárny edém, nereagujúca zrenička, pupilárny blok, glaukóm, závažný zápal oka, iritída, uveitída, strata sklovca a transplantácia rohovky. Pred zvažovaním zákroku EVO/EVO+ ICL absolvujte kompletné očné vyšetrenie a porozprávajte sa s očným špecialistom o priebehu, zahrňujúc potenciálne prínosy, riziká a možné komplikácie. Porozprávajte sa aj o čase potrebnom na hojenie po zákroku.

References

Referencie

1. Martínez-Plaza E, López-Miguel A, López-de la Rosa A, et al. Effect of the EVO+ Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life, Am J Ophthalmol 2021;226:117-125.

2. Packer M. Evaluation of the EVO/EVO+ Sphere and Toric Visian ICL: Six month results from the United States Food and Drug Administration clinical trial. Clin Ophthalmol. 2022;16:1541-53.

3. Zhang H, Deng Y, Ma K, Yin H, Tang J. Analysis on the changes of objective indicators of dry eye after implantable collamer lens (ICL) implantation surgery. Graefes Arch Clin Exp Ophthalmol. 2024 Jul; 262(7):2321-2328

4. Shoja, MR. Besharati, MR. Dry eye after LASIK for myopia: Incidence and risk factors. Eur J of Ophthalmol. 2007; 17(1): pp. 1-6.

5. Lee, Jae Bum et al. Comparison of tear secretion and tear film instability after photorefractive keratectomy and laser in situ keratomileusis. J Cataract Refract Surg., Volume 26 , Issue 9 , 1326 - 1331.

6. Albo C, Nasser T, Szynkarski DT, Nguyen N, Mueller B, Libfraind L, Parkhurst G. A Comprehensive Retrospective Analysis of EVO/EVO+ Implantable Collamer Lens: Evaluating Refractive Outcomes in the Largest Single Center Study of ICL Patients in the United States. Clin Ophthalmol. 2024 Jan 9;18:69-78.

7. Packer M. The Implantable Collamer Lens with a central port: review of the literature. Clin Ophthalmol. 2018;12:2427-2438.